Report Detail
Global Autologous Biologics Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4507093 |
- 04 February, 2023 |
- Global |
- 108 Pages |
- GIR (Global Info Research) |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Autologous Biologics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Autologous Biologics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Autologous Biologics market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Autologous Biologics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Autologous Biologics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Autologous Biologics market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Autologous Biologics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Autologous Biologics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics and Opexa Therapeutics, Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Autologous Biologics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Adipose Tissue
Plasma
Others
Market segment by Application
Hospitals
Ambulatory Centers
Research Centers
Major players covered
Vericel Corporation
BioTime, Inc.
Pharmicell Co.
BrainStorm Cell Therapeutics
Opexa Therapeutics, Inc
Pharmicell Co., Inc
Neostem
Dendreon Corporation
Regenexx
Cytori Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Autologous Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Autologous Biologics, with price, sales, revenue and global market share of Autologous Biologics from 2018 to 2023.
Chapter 3, the Autologous Biologics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Autologous Biologics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Autologous Biologics market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Autologous Biologics.
Chapter 14 and 15, to describe Autologous Biologics sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Autologous Biologics
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Autologous Biologics Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Adipose Tissue
- 1.3.3 Plasma
- 1.3.4 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Autologous Biologics Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospitals
- 1.4.3 Ambulatory Centers
- 1.4.4 Research Centers
- 1.5 Global Autologous Biologics Market Size & Forecast
- 1.5.1 Global Autologous Biologics Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Autologous Biologics Sales Quantity (2018-2029)
- 1.5.3 Global Autologous Biologics Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Vericel Corporation
- 2.1.1 Vericel Corporation Details
- 2.1.2 Vericel Corporation Major Business
- 2.1.3 Vericel Corporation Autologous Biologics Product and Services
- 2.1.4 Vericel Corporation Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Vericel Corporation Recent Developments/Updates
- 2.2 BioTime, Inc.
- 2.2.1 BioTime, Inc. Details
- 2.2.2 BioTime, Inc. Major Business
- 2.2.3 BioTime, Inc. Autologous Biologics Product and Services
- 2.2.4 BioTime, Inc. Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 BioTime, Inc. Recent Developments/Updates
- 2.3 Pharmicell Co.
- 2.3.1 Pharmicell Co. Details
- 2.3.2 Pharmicell Co. Major Business
- 2.3.3 Pharmicell Co. Autologous Biologics Product and Services
- 2.3.4 Pharmicell Co. Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Pharmicell Co. Recent Developments/Updates
- 2.4 BrainStorm Cell Therapeutics
- 2.4.1 BrainStorm Cell Therapeutics Details
- 2.4.2 BrainStorm Cell Therapeutics Major Business
- 2.4.3 BrainStorm Cell Therapeutics Autologous Biologics Product and Services
- 2.4.4 BrainStorm Cell Therapeutics Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 BrainStorm Cell Therapeutics Recent Developments/Updates
- 2.5 Opexa Therapeutics, Inc
- 2.5.1 Opexa Therapeutics, Inc Details
- 2.5.2 Opexa Therapeutics, Inc Major Business
- 2.5.3 Opexa Therapeutics, Inc Autologous Biologics Product and Services
- 2.5.4 Opexa Therapeutics, Inc Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Opexa Therapeutics, Inc Recent Developments/Updates
- 2.6 Pharmicell Co., Inc
- 2.6.1 Pharmicell Co., Inc Details
- 2.6.2 Pharmicell Co., Inc Major Business
- 2.6.3 Pharmicell Co., Inc Autologous Biologics Product and Services
- 2.6.4 Pharmicell Co., Inc Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Pharmicell Co., Inc Recent Developments/Updates
- 2.7 Neostem
- 2.7.1 Neostem Details
- 2.7.2 Neostem Major Business
- 2.7.3 Neostem Autologous Biologics Product and Services
- 2.7.4 Neostem Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Neostem Recent Developments/Updates
- 2.8 Dendreon Corporation
- 2.8.1 Dendreon Corporation Details
- 2.8.2 Dendreon Corporation Major Business
- 2.8.3 Dendreon Corporation Autologous Biologics Product and Services
- 2.8.4 Dendreon Corporation Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Dendreon Corporation Recent Developments/Updates
- 2.9 Regenexx
- 2.9.1 Regenexx Details
- 2.9.2 Regenexx Major Business
- 2.9.3 Regenexx Autologous Biologics Product and Services
- 2.9.4 Regenexx Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Regenexx Recent Developments/Updates
- 2.10 Cytori Therapeutics
- 2.10.1 Cytori Therapeutics Details
- 2.10.2 Cytori Therapeutics Major Business
- 2.10.3 Cytori Therapeutics Autologous Biologics Product and Services
- 2.10.4 Cytori Therapeutics Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Cytori Therapeutics Recent Developments/Updates
3 Competitive Environment: Autologous Biologics by Manufacturer
- 3.1 Global Autologous Biologics Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Autologous Biologics Revenue by Manufacturer (2018-2023)
- 3.3 Global Autologous Biologics Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Autologous Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Autologous Biologics Manufacturer Market Share in 2022
- 3.4.2 Top 6 Autologous Biologics Manufacturer Market Share in 2022
- 3.5 Autologous Biologics Market: Overall Company Footprint Analysis
- 3.5.1 Autologous Biologics Market: Region Footprint
- 3.5.2 Autologous Biologics Market: Company Product Type Footprint
- 3.5.3 Autologous Biologics Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Autologous Biologics Market Size by Region
- 4.1.1 Global Autologous Biologics Sales Quantity by Region (2018-2029)
- 4.1.2 Global Autologous Biologics Consumption Value by Region (2018-2029)
- 4.1.3 Global Autologous Biologics Average Price by Region (2018-2029)
- 4.2 North America Autologous Biologics Consumption Value (2018-2029)
- 4.3 Europe Autologous Biologics Consumption Value (2018-2029)
- 4.4 Asia-Pacific Autologous Biologics Consumption Value (2018-2029)
- 4.5 South America Autologous Biologics Consumption Value (2018-2029)
- 4.6 Middle East and Africa Autologous Biologics Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Autologous Biologics Sales Quantity by Type (2018-2029)
- 5.2 Global Autologous Biologics Consumption Value by Type (2018-2029)
- 5.3 Global Autologous Biologics Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Autologous Biologics Sales Quantity by Application (2018-2029)
- 6.2 Global Autologous Biologics Consumption Value by Application (2018-2029)
- 6.3 Global Autologous Biologics Average Price by Application (2018-2029)
7 North America
- 7.1 North America Autologous Biologics Sales Quantity by Type (2018-2029)
- 7.2 North America Autologous Biologics Sales Quantity by Application (2018-2029)
- 7.3 North America Autologous Biologics Market Size by Country
- 7.3.1 North America Autologous Biologics Sales Quantity by Country (2018-2029)
- 7.3.2 North America Autologous Biologics Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Autologous Biologics Sales Quantity by Type (2018-2029)
- 8.2 Europe Autologous Biologics Sales Quantity by Application (2018-2029)
- 8.3 Europe Autologous Biologics Market Size by Country
- 8.3.1 Europe Autologous Biologics Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Autologous Biologics Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Autologous Biologics Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Autologous Biologics Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Autologous Biologics Market Size by Region
- 9.3.1 Asia-Pacific Autologous Biologics Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Autologous Biologics Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Autologous Biologics Sales Quantity by Type (2018-2029)
- 10.2 South America Autologous Biologics Sales Quantity by Application (2018-2029)
- 10.3 South America Autologous Biologics Market Size by Country
- 10.3.1 South America Autologous Biologics Sales Quantity by Country (2018-2029)
- 10.3.2 South America Autologous Biologics Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Autologous Biologics Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Autologous Biologics Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Autologous Biologics Market Size by Country
- 11.3.1 Middle East & Africa Autologous Biologics Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Autologous Biologics Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Autologous Biologics Market Drivers
- 12.2 Autologous Biologics Market Restraints
- 12.3 Autologous Biologics Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Autologous Biologics and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Autologous Biologics
- 13.3 Autologous Biologics Production Process
- 13.4 Autologous Biologics Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Autologous Biologics Typical Distributors
- 14.3 Autologous Biologics Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Autologous Biologics. Industry analysis & Market Report on Autologous Biologics is a syndicated market report, published as Global Autologous Biologics Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Autologous Biologics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
